Acoustic Stimulation for Sleep Deprivation
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests whether brief sounds played during sleep can restore energy and improve performance after extended wakefulness. The Philips SmartSleep Acoustic Stimulation Device delivers these sounds during deep sleep. Participants will receive either actual sound stimulation or a sham treatment without sounds. This trial suits healthy adults aged 18 to 39 who sleep 6-9 hours per night and do not have sleep problems or use substances like caffeine or alcohol excessively. As an unphased trial, it offers participants the chance to contribute to innovative research that could enhance sleep quality and overall well-being.
Will I have to stop taking my current medications?
The trial does not specify if you must stop taking your current medications, but it mentions that certain medications may not be allowed on a case-by-case basis. It's best to discuss your specific medications with the trial coordinators.
What prior data suggests that the Philips SmartSleep Acoustic Stimulation Device is safe for use during sleep deprivation recovery?
Research on the Philips SmartSleep Acoustic Stimulation Device shows it is generally safe for people. Several studies have used the device to improve sleep quality. In these studies, users reported that the device was easy to use and did not cause any major problems. This suggests that the device is safe, with minimal risk to participants.12345
Why are researchers excited about this trial?
Most treatments for sleep deprivation involve medications or behavioral therapies to help improve sleep quality. However, the Philips SmartSleep Acoustic Stimulation Device is unique because it uses sound waves to enhance slow-wave sleep, which is the most restorative sleep phase. This device targets the brain's natural rhythms during sleep, aiming to improve recovery without relying on pharmaceuticals. Researchers are excited about this treatment because it offers a non-invasive, drug-free alternative that could enhance the body's natural sleep processes, potentially leading to better cognitive and physical recovery in a shorter time.
What evidence suggests that the Philips SmartSleep Acoustic Stimulation Device is effective for sleep deprivation?
Research has shown that sound can enhance the benefits of sleep, helping individuals feel more alert and perform better after insufficient rest. In this trial, participants will receive either acoustic stimulation or a sham treatment using the Philips SmartSleep device. This device plays soft sounds during deep sleep to improve sleep quality. Early results indicate that users feel more refreshed upon waking. Interest in how this device aids recovery from sleep loss is growing, but further research is needed to understand its effects after sleep deprivation.12367
Are You a Good Fit for This Trial?
This trial is for healthy adults aged 18-39 who understand the study well (score at least 80% on a quiz), speak English as their first language, have a BMI below 30, sleep normally without disorders or irregularities, and don't use certain substances or medications. Pregnant women and regular smokers are excluded.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Sleep Deprivation
Participants undergo 40 hours of sleep deprivation
Recovery Sleep
Participants receive either acoustic stimulation or sham during a four-hour recovery sleep period over two nights
Follow-up
Participants are monitored for performance and mood using various tests and scales
What Are the Treatments Tested in This Trial?
Interventions
- Philips SmartSleep Acoustic Stimulation Device
- Sham (no Acoustic Stimulation)
Philips SmartSleep Acoustic Stimulation Device is already approved in European Union, United States for the following indications:
- Sleep disorders
- Insomnia
- Circadian rhythm disorders
- Sleep disorders
- Insomnia
- Circadian rhythm disorders
Find a Clinic Near You
Who Is Running the Clinical Trial?
Walter Reed Army Institute of Research (WRAIR)
Lead Sponsor
Philips Healthcare
Industry Sponsor
Roy Jakobs
Philips Healthcare
Chief Executive Officer since 2022
Master's in Business Administration from Radboud University Nijmegen and Universitร degli Studi di Bologna
Dr. Roy Jakobs
Philips Healthcare
Chief Medical Officer
MD from McGill University